Mikakeen 500 Injection
Marketer
Biogenius Labs
Salt Composition
Amikacin (500mg)
Overview Mikakeen 500 Injection
Cefamox 500 Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, skeletal system, lungs (such as pneumonia), central nervous system, and bloodstream. This antibiotic is also prophylactically administered to hospitalized individuals to mitigate infection risk. Cefamox 500 Injection's mechanism involves bacterial growth inhibition. Administration, strictly under medical supervision, occurs via intravenous infusion or direct injection into a vein or muscle; self-administration is prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial; incomplete courses may result in relapse or exacerbation. Commonly reported adverse effects include injection site reactions and elevated blood urea nitrogen levels. Persistent side effects or lack of improvement warrant immediate medical consultation. High-dose regimens may induce vertigo, nephrotoxicity, and ototoxicity, necessitating close physician monitoring, including regular kidney function, hearing, and urinalysis assessments. Pregnancy contraindicates the use of this medication; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Mikakeen 500 Injection
Infections caused by bacteria
Major Benefits of Mikakeen 500 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikakeen 500 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikakeen 500 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Mikakeen 500 Injection works:
Mikakeen 500 Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Mikakeen 500 Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Mikakeen 500 Injection to pregnant individuals poses a confirmed risk to the fetus. Its use during pregnancy is therefore inadvisable except in exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Mikakeen 500 poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, with no demonstrable harm to infants.
DrivingUNSAFE
The injection Mikakeen 500 can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administration of Mikakeen 500 Injection requires careful consideration. Dosage modification of Mikakeen 500 Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Mikakeen 500 Injection appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary in such cases. Physician consultation is recommended.
What if you forget to take Mikakeen 500 Injection :
Omit a Mikakeen 500 Injection dose? Seek medical advice immediately.
Facts to Know About Mikakeen 500 Injection
| Label | Value |
|---|---|
| Type of Compound | Aminoglycoside antibiotics |
| Potential for Dependence | None. |
| Medication Classification | Drugs combating infection |
| Mechanism of Action | Amino glycoside antibiotics |
3,018 People bought this recently